Quetiapine Fumarate Tablet
Product Images NDC 71335-2422

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine Fumarate (NDC 71335-2422). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 01)

Chemical structure of quetiapine fumarate, showing the molecular arrangement of quetiapine coupled with fumarate ions. The diagram illustrates the chemical bonds and atoms within the compound used as an active ingredient in the 50 mg tablet formulation.*

FDA Label Image

Figure 1 (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 02)

A Kaplan-Meier plot showing the proportion of patients with relapse (%) over time (weeks). Two groups are compared: one receiving Quetiapine fumarate plus lithium/valproate (QTP+LI/VAL) indicated by a dashed line, and a placebo plus lithium/valproate group (PLA+LI/VAL) indicated by a solid line. The graph illustrates relapse rates up to 100 weeks.*

FDA Label Image

Figure 2 (E6dd3e1f 31d1 4d58 A717 D0bb4a4b8b6d 03)

A Kaplan-Meier curve showing the proportion of patients with relapse (%) over time in weeks (up to 100 weeks). Two treatment groups are compared: QTP+LI/VAL (quetiapine fumarate combined with lithium/valproate) represented by a dashed line, and PLA+LI/VAL (placebo combined with lithium/valproate) represented by a solid line. The graph illustrates relapse proportions increasing over time, with the PLA+LI/VAL group showing a higher relapse proportion than the QTP+LI/VAL group.*

FDA Label Image

Label (Lbl713352422)

Quetiapine fumarate 50 mg tablet label showing the product name as QUETiapine Tablets, USP. The label indicates each film-coated tablet contains 57.56 mg of quetiapine fumarate equivalent to 50 mg of quetiapine. The package contains 30 tablets and is labeled Rx only. It is repackaged by Bryant Ranch Prepack, Inc., Burbank, CA and manufactured by Lupin Limited. Storage instructions advise keeping medication out of children's reach and storing at 20° to 25°C (68° to 77°F). The NDC is 71335-2422-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.